Navigating post-approval research and reimbursement for orphan therapies
In the first of this series, we discussed how innovators can be more strategic and effective about reimbursement and address…
Opinion
Germany’s COP28 message is undermined by its domestic climate action crisis
How commercial employer plans and coverage matter for orphan drugs
Opinion: New Brexit deal can only be a good thing for Northern Ireland
Opinion: Economic isolation of China increases risk of a Taiwan invasion
Opinion: Macron talks the talk, but France’s support for Ukraine is just embarrassing
Opinion: Scotland should look to Ireland for lessons in FDI
Opinion: The UK has lost more than a monarch with the passing of Queen Elizabeth II
